These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19388838)

  • 21. Current therapies for pseudomonas aeruginosa.
    Giamarellou H; Kanellakopoulou K
    Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosing strategies to improve the treatment of Pseudomonas aeruginosa.
    Martin SJ
    Crit Care Med; 2012 Apr; 40(4):1389-90. PubMed ID: 22425861
    [No Abstract]   [Full Text] [Related]  

  • 23. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Proceedings: Prevention of the Pyocyaneus infections].
    Tanner F; Schäfer H; Jekić M; Andrasina J
    Hefte Unfallheilkd; 1973; 114():127-33. PubMed ID: 4205707
    [No Abstract]   [Full Text] [Related]  

  • 25. [In vitro sensitivity of 39 strains of Pseudomonas aeruginosa isolated from urine culture of hospitalized patients].
    Vanni M; Zucca C
    Minerva Med; 1986 Jun; 77(27):1289-92. PubMed ID: 3088493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminoglycoside-resistant Pseudomonas aeruginosa urinary tract infection: study of an outbreak.
    Smith PW; Rusnak PG
    J Hosp Infect; 1981 Mar; 2(1):71-5. PubMed ID: 6176627
    [No Abstract]   [Full Text] [Related]  

  • 27. Susceptibility patterns in Pseudomonas aeruginosa causing nosocomial infections.
    Astal Z
    J Chemother; 2004 Jun; 16(3):264-8. PubMed ID: 15330323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large outbreak in a surgical intensive care unit of colonization or infection with Pseudomonas aeruginosa that overexpressed an active efflux pump.
    Bertrand X; Bailly P; Blasco G; Balvay P; Boillot A; Talon D
    Clin Infect Dis; 2000 Oct; 31(4):E9-E14. PubMed ID: 11049805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urinary tract infections].
    Arakawa S
    Nihon Rinsho; 2002 Nov; 60(11):2200-3. PubMed ID: 12440130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of blaVIM-2 carbapenemase in Pseudomonas aeruginosa in Ireland.
    Walsh F; Rogers TR
    J Antimicrob Chemother; 2008 Jan; 61(1):219-20. PubMed ID: 18024489
    [No Abstract]   [Full Text] [Related]  

  • 31. Advances in the management of pneumonia in the intensive care unit: review of current thinking.
    Rello J; Diaz E; Rodríguez A
    Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():30-8. PubMed ID: 16138817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates.
    Pires dos Santos R; Jacoby T; Pires Machado D; Lisboa T; Gastal SL; Nagel FM; Kuplich NM; Konkewicz L; Gorniak Lovatto C; Pires MR; Goldani LZ
    Infect Control Hosp Epidemiol; 2011 Jun; 32(6):584-90. PubMed ID: 21558771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa is not just in the intensive care unit any more: implications for empirical therapy.
    Eagye KJ; Banevicius MA; Nicolau DP
    Crit Care Med; 2012 Apr; 40(4):1329-32. PubMed ID: 22425824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The treatment of Pseudomonas aeruginosa infections; current status and future strategies].
    Saito A; Watanabe A; Kusano ; Kusachi S
    Jpn J Antibiot; 2002 Oct; 55(5):483-92. PubMed ID: 12532632
    [No Abstract]   [Full Text] [Related]  

  • 35. Review: Antibiotic discovery in the age of structural biology - a comprehensive overview with special reference to development of drugs for the treatment of Pseudomonas aeruginosa infection.
    Koehnke A; Friedrich RE
    In Vivo; 2015; 29(2):161-7. PubMed ID: 25792642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of tap water and environmental surfaces to nosocomial transmission of antibiotic-resistant Pseudomonas aeruginosa.
    Muscarella LF
    Infect Control Hosp Epidemiol; 2004 Apr; 25(4):342-5. PubMed ID: 15108733
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiresistant Pseudomonas aeruginosa associated with contaminated transrectal ultrasound.
    Paz A; Bauer H; Potasman I
    J Hosp Infect; 2001 Oct; 49(2):148-9. PubMed ID: 11567566
    [No Abstract]   [Full Text] [Related]  

  • 38. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
    Khan JA; Iqbal Z; Rahman SU; Farzana K; Khan A
    Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial.
    Tsukayama DT; van Loon HJ; Cartwright C; Chmielewski B; Fluit AC; van der Werken C; Verhoef J;
    Int J Antimicrob Agents; 2004 Oct; 24(4):339-45. PubMed ID: 15380258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.